Drug Supply Chain Security Act compliance policy guidances establish 1-year stabilization period for implementation of electronic interoperable systems
Drug Supply Chain Security Act compliance policy guidances establish 1-year stabilization period for implementation of electronic interoperable systems
Quick Take
The FDA has established a one-year stabilization period for the final implementation of the Drug Supply Chain Security Act (DSCSA), extending the deadline for electronic, interoperable package-level tracing to November 27, 2024. This move provides the pharmaceutical supply chain, including dispensing clinics, additional time to refine the complex digital systems required to track prescription drugs.
Why It Matters
For eye care practices that dispense prescription medications or biologics, this delay is a significant reprieve from a looming regulatory cliff. The DSCSA requires a seamless digital 'handshake' between manufacturers, wholesalers, and providers to prevent counterfeit drugs from entering the market, but the technical implementation has proven difficult for many smaller entities. This stabilization period ensures that patient care isn't interrupted by supply chain gridlock caused by technical data mismatches or system interoperability issues.
Key Details
Practice Implications
Practice owners should use this additional year to verify that their inventory management systems are capable of receiving and storing required Transaction Information (TI) and Transaction Statements (TS) electronically. It is critical to communicate with wholesalers now to ensure that your practice's digital receiving process is fully integrated and compliant before the new 2024 deadline.
Who's Affected
What's Next
The FDA will monitor the industry's progress throughout 2024 to ensure systems are ready for the final transition. Practices should aim to have their electronic tracking systems fully operational well ahead of the November 2024 deadline to avoid potential shipment rejections.
AI-generated summary — always read the original source for full context
No comments yet. Be the first to share your thoughts.